FBIO

Fortress Biotech (FBIO)

Fortress Biotech Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:FBIO

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/16	05:15	GlobeNewswire Inc.	Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights	NASDAQ:FBIO	Fortress Biotech Inc
2024/05/16	05:01	GlobeNewswire Inc.	Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase	NASDAQ:FBIO	Fortress Biotech Inc
2024/05/15	21:30	GlobeNewswire Inc.	Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights	NASDAQ:FBIO	Fortress Biotech Inc
2024/05/14	21:30	GlobeNewswire Inc.	Fortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver Transplantation	NASDAQ:FBIO	Fortress Biotech Inc
2024/05/14	05:01	GlobeNewswire Inc.	Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights	NASDAQ:FBIO	Fortress Biotech Inc
2024/05/07	21:30	GlobeNewswire Inc.	Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024	NASDAQ:FBIO	Fortress Biotech Inc
2024/05/03	05:01	GlobeNewswire Inc.	Mustang Bio Announces Closing of $4 Million Public Offering	NASDAQ:FBIO	Fortress Biotech Inc
2024/05/02	05:01	GlobeNewswire Inc.	Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer	NASDAQ:FBIO	Fortress Biotech Inc
2024/04/30	09:00	GlobeNewswire Inc.	Mustang Bio Announces Pricing of $4 Million Public Offering	NASDAQ:FBIO	Fortress Biotech Inc
2024/04/29	21:00	GlobeNewswire Inc.	Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds	NASDAQ:FBIO	Fortress Biotech Inc
2024/04/25	21:30	GlobeNewswire Inc.	Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024	NASDAQ:FBIO	Fortress Biotech Inc
2024/04/24	20:30	GlobeNewswire Inc.	Avenue Therapeutics Announces Reverse Stock Split	NASDAQ:FBIO	Fortress Biotech Inc
2024/03/29	05:05	GlobeNewswire Inc.	Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights	NASDAQ:FBIO	Fortress Biotech Inc
2024/03/28	22:00	GlobeNewswire Inc.	Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases	NASDAQ:FBIO	Fortress Biotech Inc
2024/03/25	21:30	GlobeNewswire Inc.	Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024	NASDAQ:FBIO	Fortress Biotech Inc
2024/03/22	05:01	GlobeNewswire Inc.	Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights	NASDAQ:FBIO	Fortress Biotech Inc
2024/03/19	05:05	GlobeNewswire Inc.	Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights	NASDAQ:FBIO	Fortress Biotech Inc
2024/03/18	21:30	GlobeNewswire Inc.	Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea	NASDAQ:FBIO	Fortress Biotech Inc
2024/03/15	21:30	GlobeNewswire Inc.	Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024	NASDAQ:FBIO	Fortress Biotech Inc
2024/03/15	21:15	GlobeNewswire Inc.	Avenue Therapeutics Receives Positive Listing Determination from Nasdaq	NASDAQ:FBIO	Fortress Biotech Inc
2024/03/13	21:30	GlobeNewswire Inc.	Journey Medical Corporation to Participate in the 36th Annual ROTH Conference	NASDAQ:FBIO	Fortress Biotech Inc
2024/03/12	21:30	GlobeNewswire Inc.	Fortress Biotech to Participate in 36th Annual ROTH Conference	NASDAQ:FBIO	Fortress Biotech Inc
2024/03/11	21:30	GlobeNewswire Inc.	Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting	NASDAQ:FBIO	Fortress Biotech Inc
2024/03/11	21:00	GlobeNewswire Inc.	Avenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting	NASDAQ:FBIO	Fortress Biotech Inc
2024/03/07	21:30	GlobeNewswire Inc.	Mustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade Glioma	NASDAQ:FBIO	Fortress Biotech Inc
2024/03/04	22:30	GlobeNewswire Inc.	Fortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes Disease	NASDAQ:FBIO	Fortress Biotech Inc
2024/02/22	22:30	GlobeNewswire Inc.	Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy	NASDAQ:FBIO	Fortress Biotech Inc
2024/01/11	22:30	GlobeNewswire Inc.	Mustang Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference	NASDAQ:FBIO	Fortress Biotech Inc
2024/01/11	22:00	GlobeNewswire Inc.	Avenue Therapeutics to Present at Sidoti January Micro-Cap Investor Conference	NASDAQ:FBIO	Fortress Biotech Inc
2024/01/05	23:15	GlobeNewswire Inc.	Avenue Therapeutics Enters into Warrant Exercise Transactions for $5.0 Million in Proceeds	NASDAQ:FBIO	Fortress Biotech Inc